Second trimester serum markers

Seminars in Perinatology

Volumn 29, Issue 4, 2005, Pages 203-208

  Canick, Jacob A ^a   MacRae, Andrew R ^b  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b LAKERIDGE HEALTH CORPORATION   (Canada)

Author keywords

Down syndrome; Hyperglycosylated hCG; Inhibin A; Prenatal screenig; Serum markers; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A;

CONFERENCE PAPER; DISEASE MARKER; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; MATERNAL AGE; MATERNAL SERUM; OBSTETRIC CARE; PERFORMANCE; PLACENTA; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; SECOND TRIMESTER PREGNANCY; URINALYSIS;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; FETAL DISEASES; FETUS; HUMANS; INHIBINS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 23644461221     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.05.011     Document Type: Conference Paper

References (25)

1. I.R. Merkatz, H.M. Nitowsky, J.N. Macri An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities Am J Obstet Gynecol 148 1984 886 894
2. M. Bogart, M.R. Pandian, O.W. Jones Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities Prenat Diagn 7 1987 623 630
3. J. Canick, G.J. Knight, G.E. Palomaki Low second trimester maternal serum unconjugated estriol in pregnancies with Down's syndrome Br J Obstet Gynaecol 95 1988 330 333
4. N.J. Wald, H.S. Cuckle, J.W. Densem Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome Br J Obstet Gynaecol 95 1988 334 341
5. N.J. Wald, H.S. Cuckle, J.W. Densem Maternal serum screening for Down's syndrome in early pregnancy Br Med J 297 1988 883 887
6. ACOG Committee Opinion. Down syndrome screening Committee on Obstetric Practice, Am Col Obstet Gynecol 1994 No. 141, Aug
7. ACOG Educational Bulletin. Maternal serum screening Am Col Obstet Gynecol 1996 No. 228, Sept
8. G.E. Palomaki, G.J. Knight, J.E. McCarthy Maternal serum screening for Down syndrome in the United States a 1995 survey Am J Obstet Gynecol 176 1997 1046 1051
9. J.M.M. Van Lith, J.J. Pratt, J.R. Beehuis Second trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome Prenat Diagn 12 1992 801 806
10. J.A. Canick, G.M. Lambert-Messerlian, G.E. Palomaki Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy Am J Hum Genet 55 1994 A9
11. G.M. Lambert-Messerlian, J.A. Canick, G.E. Palomaki Second trimester levels of maternal serum inhibin-A, total inhibin, α inhibin precursor and activin in Down's syndrome pregnancies J Med Screen 3 1996 58 62
12. N. Wald, J. Densem, L. George Prenatal screening for Down's syndrome using inhibin-A as a serum marker Prenat Diagn 16 1996 143 153
13. D.A. Aitken, E.M. Wallace, J.A. Crossley Dimeric inhibin-A as a marker for Down's syndrome in early pregnancy N Engl J Med 334 1996 1231 1236
14. H.S. Cuckle, S. Holding, R. Jones Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome Prenat Diagn 16 1996 1095 1100
15. K. Spencer, E.M. Wallace, S. Ritoe Second trimester dimeric inhibin-A in Down's syndrome screening Prenat Diagn 16 1996 1101 1110
16. E. Wallace, I. Swantston, V. Grant Second trimester screening for Down's syndrome using serum dimeric inhibin-A Clin Endocrinol 44 1996 17 21
17. N.J. Wald, C. Rodeck, A.K. Hackshaw First and second trimester antenatal screening for Down's syndrome the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) J Med Screen 10 2003 56 104
18. Malone FD, Canick JA, Ball RH,, et al. First and second trimester evaluation of risk for fetal aneuploidy (FASTER): Principal results of the NICHD multicenter Down syndrome screening study. N Engl J Med 2005 (in press)
19. J.E. Haddow, G.E. Palomaki, G.J. Knight Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A J Med Screen 5 1998 115 119
20. G.J. Knight, G.E. Palomaki Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome Clin Lab Med 23 2003 531 551
21. L.A. Cole, S. Shahabi, U.A. Oz Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay a new basis for gestational Down syndrome screening Clin Chem 45 1999 2109 2119
22. H.S. Cuckle, S. Shahabi, I.K. Schmi Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome Prenat Diagn 19 1999 918 920
23. R. Pandian, L.A. Cole, G.E. Palomaki Second-trimester maternal serum invasive trophoblast antigen a marker for Down syndrome screening Clin Chem 50 2004 1433 1435
24. G.E. Palomaki, L.M. Neveux, G.J. Knight Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester Clin Chem 50 2004 1804 1808
25. G.E. Palomaki, G.J. Knight, M.M. Roberson Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for Down syndrome preliminary results of an observational study on fresh samples Clin Chem 50 2004 182 189